SULAIMAN ALHABIB

Dr. Sulaiman Al-Habib Medical Services Group Co.

4013StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	74.83B	89.95B	98.14B	99.40B	77.21B
Market Cap Growth	-17.1%	-8.3%	-1.3%	+28.7%	+36.7%
Enterprise Value	82.45B	97.42B	103.46B	102.18B	78.54B
Last Close Price	213.80	254.46	272.83	271.97	207.94
Valuation Multiples
Forward PE (Next 12M Est.)	26.90	33.36	39.40	45.09	44.39
PE Ratio	31.87	37.46	42.39	48.58	46.77
PEG Ratio	2.30	2.30	2.27	2.45	2.22
PS Ratio	5.35	6.56	8.76	10.45	9.29
PB Ratio	8.82	10.67	12.89	14.69	12.65
P/TBV Ratio	9.41	11.38	13.68	15.33	13.13
P/FCF Ratio	62.28	214.86	—	—	58.04
P/OCF Ratio	20.10	26.44	33.04	30.64	27.15
EV/Sales Ratio	5.90	7.11	9.24	10.75	9.45
EV/EBITDA Ratio	24.72	30.51	38.16	43.33	40.06
EV/EBIT Ratio	31.68	37.20	43.91	48.76	46.18
EV/FCF Ratio	68.62	232.71	—	—	59.04
Leverage & Capital
Debt / Equity Ratio	1.12	1.10	1.07	0.77	0.58
Debt / EBITDA Ratio	2.87	2.83	2.94	2.15	1.75
Debt / FCF Ratio	7.91	22.23	—	—	2.65
Net Debt / Equity Ratio	0.84	0.83	0.69	0.38	0.13
Net Debt / EBITDA Ratio	2.20	2.20	1.95	1.09	0.40
Net Debt / FCF Ratio	5.90	16.78	-6.15	-10.14	0.58
Efficiency & Liquidity
Asset Turnover	0.62	0.63	0.62	0.67	0.71
Inventory Turnover	9.47	10.15	10.75	12.10	12.43
Quick Ratio	0.82	0.84	0.98	1.01	1.35
Current Ratio	1.14	1.15	1.28	1.25	1.61
Returns & Yields
Return on Equity (ROE)	+29.9%	+31.1%	+33.0%	+32.7%	+29.0%
Return on Assets (ROA)	+7.1%	+7.5%	+8.1%	+9.2%	+9.1%
Return on Invested Capital (ROIC)	+16.3%	+18.3%	+20.8%	+25.0%	+24.9%
Return on Capital Employed (ROCE)	+13.7%	+14.2%	+14.4%	+16.8%	+17.0%
Earnings Yield	+3.1%	+2.7%	+2.4%	+2.1%	+2.1%
FCF Yield	+1.6%	+0.5%	-0.9%	-0.3%	+1.7%
Dividend Yield	+2.3%	+1.9%	+1.7%	+1.6%	+1.7%
Payout Ratio	+72.0%	+69.2%	+70.9%	+70.1%	+68.9%
Total Shareholder Return	+2.3%	+1.9%	+1.7%	+1.6%	+1.7%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	74.83B	89.95B	98.14B	99.40B	77.21B
Market Cap Growth	-17.1%	-8.3%	-1.3%	+28.7%	+36.7%
Enterprise Value	82.45B	97.42B	103.46B	102.18B	78.54B
Last Close Price	213.80	254.46	272.83	271.97	207.94
Valuation Multiples
Forward PE (Next 12M Est.)	26.90	33.36	39.40	45.09	44.39
PE Ratio	31.87	37.46	42.39	48.58	46.77
PEG Ratio	2.30	2.30	2.27	2.45	2.22
PS Ratio	5.35	6.56	8.76	10.45	9.29
PB Ratio	8.82	10.67	12.89	14.69	12.65
P/TBV Ratio	9.41	11.38	13.68	15.33	13.13
P/FCF Ratio	62.28	214.86	—	—	58.04
P/OCF Ratio	20.10	26.44	33.04	30.64	27.15
EV/Sales Ratio	5.90	7.11	9.24	10.75	9.45
EV/EBITDA Ratio	24.72	30.51	38.16	43.33	40.06
EV/EBIT Ratio	31.68	37.20	43.91	48.76	46.18
EV/FCF Ratio	68.62	232.71	—	—	59.04
Leverage & Capital
Debt / Equity Ratio	1.12	1.10	1.07	0.77	0.58
Debt / EBITDA Ratio	2.87	2.83	2.94	2.15	1.75
Debt / FCF Ratio	7.91	22.23	—	—	2.65
Net Debt / Equity Ratio	0.84	0.83	0.69	0.38	0.13
Net Debt / EBITDA Ratio	2.20	2.20	1.95	1.09	0.40
Net Debt / FCF Ratio	5.90	16.78	-6.15	-10.14	0.58
Efficiency & Liquidity
Asset Turnover	0.62	0.63	0.62	0.67	0.71
Inventory Turnover	9.47	10.15	10.75	12.10	12.43
Quick Ratio	0.82	0.84	0.98	1.01	1.35
Current Ratio	1.14	1.15	1.28	1.25	1.61
Returns & Yields
Return on Equity (ROE)	+29.9%	+31.1%	+33.0%	+32.7%	+29.0%
Return on Assets (ROA)	+7.1%	+7.5%	+8.1%	+9.2%	+9.1%
Return on Invested Capital (ROIC)	+16.3%	+18.3%	+20.8%	+25.0%	+24.9%
Return on Capital Employed (ROCE)	+13.7%	+14.2%	+14.4%	+16.8%	+17.0%
Earnings Yield	+3.1%	+2.7%	+2.4%	+2.1%	+2.1%
FCF Yield	+1.6%	+0.5%	-0.9%	-0.3%	+1.7%
Dividend Yield	+2.3%	+1.9%	+1.7%	+1.6%	+1.7%
Payout Ratio	+72.0%	+69.2%	+70.9%	+70.1%	+68.9%
Total Shareholder Return	+2.3%	+1.9%	+1.7%	+1.6%	+1.7%